+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Inflammatory Bowel Disease Drug"

Inflammatory Bowel Disease Treatment Market By Type, By Distribution Channel, By Route of Administration, By Drug Class, By Regional Outlook, Industry Analysis Report and Forecast, 2021 - 2027 - Product Thumbnail Image

Inflammatory Bowel Disease Treatment Market By Type, By Distribution Channel, By Route of Administration, By Drug Class, By Regional Outlook, Industry Analysis Report and Forecast, 2021 - 2027

  • Report
  • October 2021
  • 288 Pages
  • Global
From
Asia Pacific Inflammatory Bowel Disease Treatment Market By Type, By Distribution Channel, By Route of Administration, By Drug Class, By Country, Opportunity Analysis and Industry Forecast, 2021 - 2027 - Product Thumbnail Image

Asia Pacific Inflammatory Bowel Disease Treatment Market By Type, By Distribution Channel, By Route of Administration, By Drug Class, By Country, Opportunity Analysis and Industry Forecast, 2021 - 2027

  • Report
  • October 2021
  • 124 Pages
  • Asia Pacific
From
North America Inflammatory Bowel Disease Treatment Market By Type, By Distribution Channel, By Route of Administration, By Drug Class, By Country, Opportunity Analysis and Industry Forecast, 2021 - 2027 - Product Thumbnail Image

North America Inflammatory Bowel Disease Treatment Market By Type, By Distribution Channel, By Route of Administration, By Drug Class, By Country, Opportunity Analysis and Industry Forecast, 2021 - 2027

  • Report
  • October 2021
  • 110 Pages
  • North America
From
Europe Inflammatory Bowel Disease Treatment Market By Type, By Distribution Channel, By Route of Administration, By Drug Class, By Country, Opportunity Analysis and Industry Forecast, 2021 - 2027 - Product Thumbnail Image

Europe Inflammatory Bowel Disease Treatment Market By Type, By Distribution Channel, By Route of Administration, By Drug Class, By Country, Opportunity Analysis and Industry Forecast, 2021 - 2027

  • Report
  • October 2021
  • 125 Pages
  • Europe
From
LAMEA Inflammatory Bowel Disease Treatment Market By Type, By Distribution Channel, By Route of Administration, By Drug Class, By Country, Opportunity Analysis and Industry Forecast, 2021 - 2027 - Product Thumbnail Image

LAMEA Inflammatory Bowel Disease Treatment Market By Type, By Distribution Channel, By Route of Administration, By Drug Class, By Country, Opportunity Analysis and Industry Forecast, 2021 - 2027

  • Report
  • October 2021
  • 124 Pages
  • Middle East, Africa
From
Inflammatory Bowel Disease Drugs Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Product Type - Product Thumbnail Image

Inflammatory Bowel Disease Drugs Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Product Type

  • Report
  • February 2024
  • 88 Pages
  • Global
From
Inflammatory Bowel Disease Drugs Market By Type, By Drug Class, By Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2021-2031 - Product Thumbnail Image

Inflammatory Bowel Disease Drugs Market By Type, By Drug Class, By Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2021-2031

  • Report
  • July 2022
  • 274 Pages
  • Global
From
Loading Indicator

The Immune Disorders Drugs market includes drugs used to treat Inflammatory Bowel Disease (IBD). IBD is a chronic condition that causes inflammation of the digestive tract, leading to abdominal pain, diarrhea, and other symptoms. IBD drugs are used to reduce inflammation and improve symptoms. These drugs include corticosteroids, immunomodulators, biologics, and other medications. Corticosteroids are used to reduce inflammation and suppress the immune system, while immunomodulators are used to modify the immune system's response to inflammation. Biologics are used to target specific molecules involved in the inflammatory process. Some companies in the IBD drug market include AbbVie, Amgen, AstraZeneca, Boehringer Ingelheim, Janssen, Merck, Pfizer, and Takeda. Show Less Read more